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Abstract
Background: Next generation sequencing (NGS) technologies have greatly facilitated the rapid and economical
detection of pathogenic mutations in human disorders. However, mutation descriptions are hard to be compared
and integrated due to various reference sequences and annotation tools adopted in different articles as well as the
nomenclature of diseases/traits.
Description: The Human Disease Associated Mutation (HDAM) database is dedicated to collect, standardize and
re-annotate mutations for human diseases discovered by NGS studies. In the current release, HDAM contains 1,114
mutations, located in 669 genes and associated with 125 human diseases through literature mining. All mutation
records have uniform and unequivocal descriptions of sequence changes according to the Human Genome
Sequence Variation Society (HGVS) nomenclature recommendations. Each entry displays comprehensive
information, including mutation location in genome (hg18/hg19), gene functional annotation, protein domain
annotation, susceptible diseases, the first literature report of the mutation and etc. Moreover, new mutation-disease
relationships predicted by Bayesian network are also presented under each mutation.
Conclusion: HDAM contains hundreds rigorously curated human mutations from NGS studies and was created to
provide a comprehensive view of these mutations that confer susceptibility to the common disorders. HDAM can
be freely accessed at http://www.megabionet.org/HDAM.
Background
Mutation is a major cause of human diseases. Scientific
studies of mutational mechanisms in human genes and
the function of mutated genes in pathological pathway to
disease are always research hotspots. With the success of
next generation sequencing technologies in past several
years, exome sequencing [1], target resequencing [2] and
whole genome sequencing [3-5] applied in studying
human disorders, such as monogenic diseases, complex
inherited diseases and cancers, have already proven their
powers to detect susceptible mutations. Thus, significant
outcomes have been accumulated. Systems biology stu-
dies have shown its critical role in mechanism illustration
and correlation prediction between mutation and dis-
ease/traits [6]. However, almost all of these studies have
to take great extra efforts on data integration from publi-
cations for both mutation description standardization
and disease category because of inconsistence between
data descriptions from different resources. Inspired by
the great achievement of some popular databases, such as
the database of Genotypes and Phenotypes (dbGaP),
which was developed to archive and distribute the results
of studies that have investigated the correlation of geno-
type and phenotype [7], we believe that a database focus-
ing on collecting mutation-disease relation and uniform
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mutation description will be meaningful and useful, espe-
cially with more and more data accumulated in future.
Nevertheless, mutations are frequently documented
with only protein and/or DNA sequence without being
clarified with reference sequence accession number or
version, which make those mutations unavailable for re-
analysis and integration. For example, mutation records
in the Online Mendelian Inheritance in Man (OMIM) [8]
Allelic Variant field often have such problems. Many
early records are described as sequence variation at pro-
tein level only based on amino acid sequences reported
in publication without protein accession IDs and versions
[9]. Since the currently annotated protein often differs
from these early sequences, the positions of some muta-
tions cannot be inferred on the current sequences. In
another word, such mutation records will lose their value
in use.
To overcome these limitations, HDAM database is
dedicated to collect and annotate mutations in nuclear
genes underlying human diseases from published NGS
studies. The core work is to uniform mutation nomencla-
ture, locate mutation at different reference genome,
record association between mutation and disease, and
integrate meaningful annotation from both text-mined
results and other databases. Particularly, the standard
syntax of mutation description is critical for its sustain-
able utilization in both molecular effects and biological
functions. Another major accomplishment of this article
is to predict new mutation-disease association through
combining OMIM Allelic Variants data. Mitochondrial
genome mutations are not included in current release.
Construction and content
Literature mining
The mutation-disease relationship records in the current
release were collected through PubMed searches using
the terms ‘(exome OR whole OR deep OR high-throughput
OR (next AND generation) OR (massively AND parallel))
AND sequencing AND mutation’. Through the abstract
scanning, only the articles which focus on studying
human diseases by the next generation sequencing were
selected for further review.
Information on the following study-level fields was
extracted from related papers: PubMed ID, PubMed
URL, publication title, patient ID, patient ethnicity, the
technique and the platform used in the study, disease
information, validation experiments. Particularly, the
disease name was checked by searching OMIM, Wikipe-
dia (http://www.wikipedia.org/), Human phenotype
Ontology (HPO) [10], Orphanet [11] and International
Classification of Diseases (ICD, http://apps.who.int/clas-
sifications/apps/icd/icd10online/). If available, the
OMIM IDs, HPO IDs and/or ICD numbers were also
assigned to corresponding phenotype.
In the process of extracting mutation-level informa-
tion, a crucial criterion has been followed: only the
mutation that can be accurately located on genome is
collected. The mutation-level information includes:
Genomic position, base change on genome, transcript
position, base change on transcript, protein position,
amino acid change, gene, chromosome number.
Several problems were encountered during text mining:
Firstly, not all above information can be extracted from
every paper. For a mutation, if only position information
on genome and base change are available, all possible
cDNA level and protein level descriptions are kept. For
example, mutation NC_000011.8:g.9794133G>A may be
located either in gene LOC283104 or gene SBF2. Because
of no more detail information about this mutation in ori-
ginal text, both of the two genes were collected into our
database. Secondly, a gene may have several cDNA refer-
ence sequences. If the cDNA accession number for a
mutation is not assigned, we preferred to keep all possi-
ble cDNA level descriptions that indicate the same
amino acids mutation as shown in original articles.
Besides, inconsistence between cDNA description and
protein description was also observed in some articles.
Under such circumstance, we used UCSC BLAT tool
[12] to check and correct the discordance. During the
whole data annotation process, we utilized Mutalyzer 2.0
b-8 [13] to check all collected data and complete infor-
mation of each mutation when some information is not
available from articles. Mutalyzer is a tool primarily
designed to check descriptions of sequence variants
according to the standard human sequence variant
nomenclature of HGVS. Therefore, it makes it possible
for us to standardize all mutation information from dif-
ferent articles. In this project, two independent reviewers
extracted information from the same articles in parallel
to ensure that they applied our inclusion criteria in the
same manner. Then, all results were checked and cor-
rected by a third reviewer.
Data integration
To further help in understanding the relationship between
mutation and disease, biological annotations under differ-
ent levels were also integrated into HDAM. On the gene
level, gene function annotation by Gene Ontology [14],
OMIM gene description, sequence information was incor-
porated into the database. On the protein level, the
domain annotation was accomplished by HMMSCAN
(http://hmmer.janelia.org/search/hmmscan), and the pro-
tein structure 3D graph with mutation labels was visua-
lized by Jmol.
OMIM represents the most complete and up-to-date
repository of all known disease genes and the disorders.
The “omim.txt” file was downloaded from OMIM website,
consisting of 21,728 OMIM records. We parsed omim file
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and extracted gene records containing Allelic Variants
(AV) field, which records the relations between the muta-
tions or polymorphisms of the genes and the phenotypes.
The disease-gene association mediated by mutations can
be more proper for exploring pathological mechanism of
mutation induced diseases. Totally, 16,574 mutations,
18,510 mutation-disease pairs and 4,549 gene-disease pairs
were extracted from 2,604 gene records.
The Bayesian network approach
As a representation of biofunctional system, Protein-
Protein Interaction (PPI) network has been widely adopted
in exploring the common or related mechanisms of com-
plex phenotypes, such as network based function module
discovery [6] and pathway tracing [16]. To facilitate under-
standing of the biological linkage between diseases and
mutations, a Bayesian network based scoring system was
built in our platform, which integrates both topological
and biological features, including disease neighbor density
by common module profiling score (CMP) [17], disease
gene function similarity by Shared Smallest Biological Pro-
cesses score (SSBP) [18]. A disease mutation preferential
interaction score (DMPI), which represents the most fre-
quently used PPIs that link the mutated genes in a given
disease, was also featured in the Bayesian network. The
DMPI is treated as an efficacious bridge that makes the
level-2 neighbor in PPI network to be available in the pre-
diction [19]. These three types of the features are hier-
archically organized in the Bayesian network. Topological
(CMP and DMPI) and biological features (SSBP) are con-
ditionally independent, while CMP and DMPI are non-
independent given a disease-mutation linkage. Golden
Standard Positive (GSP) dataset contains the disease-
mutation relations that were manually collected from pub-
lished sequencing results and OMIM Allelic Variants. As
less result is available for the non-disease oriented muta-
tion, Golden Standard Negative (GSN) dataset was con-
structed by random combining diseases with the
mutations that were annotated in a sufficient distance,
where the distance was calculated in the HPO category
tree. The confidence score for each inferred disease and
mutation linkage was defined as the posterior probability
of the hierarchical Bayesian network. Totally, 229,309 new
mutation-disease relations have been predicted based on
HPO, with Likelihood Ratio larger than 685 and FDR as
0.03.
Record description
Each mutation recorded in HDAM was given a unique
identifier. Each mutation has three level symbols, includ-
ing genome, cDNA and protein. The symbol is con-
structed with sequence accession number in GenBank,
sequence type symbol, mutation position and sequence
change. For example, NM_020975.4:c.2944C>T refers a
C®T substitution happened at position 2944 on cDNA
sequence NM_020975.4; NP_009008.2:p.Arg42* indicates
that Arginine at position 42 on protein sequence
NP_009008.2 is mutated to a stop codon. All mutation
symbols used in our database follow the HGVS nomen-
clature recommendations faithfully [20].
A HDAM entry comprises a mutation located gene,
chromosomal location, protein domain, associated disease,
the reference to the literature report of this mutation and
some details in the literature (eg. The technique, platform,
sample ethnicity and description of this mutation).
Besides, annotation integrated from other sources, such as
OMIM and GO, is also available. Moreover, predicted new
mutation-disease pairs with Bayesian Network are pre-
sented in each mutation entry.
Utility and discussion
Utility
To provide a systemic gateway for mutation-disease rela-
tionship exploration, we implemented several search fea-
tures on the website, including mutation description
syntaxes (e.g. ‘p.Gly1349Asp’), reported gene name (e.g.
‘CFTR’), chromosomal region (e.g. ‘chr1:100000-200000’),
disease (string search or multiple option search), or
OMIM disease IDs. To browse the results, the reference
genome version (hg18/NCBI36 and hg19/NCBI37) must
be selected before search. After submission, a result list is
displayed, including mutation ID, mutation description on
genome level, mutation description on cDNA level, muta-
tion description on protein level, mutation type, mutation
effect, associated diseases and PubMed IDs (Figure 1.1).
To see more details about a mutation, the user can click
the “view” button and a new page will appear to display all
information about this mutation, both from manual col-
lection and integration.
The mutation page can be separated into three sections:
1) the basic annotation, 2) the reference and 3) the predic-
tion (Figure 1.2). The basic annotation includes: 1) the
position both on hg18 and hg19; 2) the standard descrip-
tion on genome level, cDNA level and protein level; 3) the
reported genes and the gene function annotation (GO); 4)
the protein domain containing mutation and the protein
structure 3D graph labeled with mutation (Figure 1.3).
The reference information reveals the ethnicity report of
the mutation, sequencing sample, methods, platform and
description of mutation in articles. In the prediction
results, new mutation-disease associations with scores and
preferential proteins mediating such predicted linkages are
shown to users. For example (Figure 1.4), the mutation
NM_000492.3:c.350G>A (id: M301052)in gene CFTR is
associated with Cystic fibrosis as reported with a signifi-
cant preferred PPI with RNF5(PMID:21228398), which
may contribute to new disease-mutation prediction in
level-2 PPI neighbors. The preferred PPI network can be
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shown in GUESS applet in the link page “SHOW THE
PREFERRED PPI PATHWAYS”(Figure 1.4.a), while, a
smaller network with only pathway nodes contained in the
link page “SHOW THE PREFERRED PPI NETWORK”
(Figure 1.4.b).All neighbor genes will be listed in disease
gene Clique tab if all the genes associated with the given
disease are significantly enriched in the level-1 neighbors
of the queried mutation
Discussion
HDAM currently contains 1,114 mutations, 669 genes
and 125 human diseases (Figure 2). There are 444 genes
in HDAM have no allelic variant records in OMIM.
Actually, these genes discovered by NGS technology
were confirmed with mutation events in patients, which
have potential biological function and clinical applica-
tions. For example, a de novo missense mutation is iden-
tified in the gene TGM3 in an autistic proband [21].
TGM3 or Transglutaminase 3 belongs to transglutami-
nase family which are enzymes that catalyze the cross-
linking of proteins by epsilon-gamma glutamyl lysine
isopeptide bonds. In this protein family, another member
TGM2 is related with autism spectrum disorders [22],
indicating that there is a possibility that TGM3 has
underlying effect on mechanism of autism. Therefore,
new mutated genes discovered by NGS technology
should be pointed out, in need of further validation
experiments. The quality and quantity of data are the
most essential and crucial characteristics for a database.
Therefore, the mutation collection will be a long-term
task with great efforts. Considering that mutation infor-
mation is widely utilized in the biomedical researches,
periodically updating genomic annotation of mutations
(e.g. position) is necessary for several reasons: 1) novel
mutations are published; 2) more annotation data and
references of existent data need to be added into
Figure 1 Searching for information of a mutation in gene EGFR via the simple gene search interface. The panel 1 on the upper left
corner is the search interface of HDAM and result table. The panel 2 on the right in the middle of the figure illustrates the content of a
mutation page. Panel 3 on the top right corner shows the protein domain containing mutation and the protein structure 3D graph labeled with
mutation via Jmol. Panel 4 on the bottom right conner shows the preferred path in PPI network (a) and the preferred PPI network (b).
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database; 3) new version of human reference genome is
published; 4) bugs and comments are collected from
feedbacks. To meet the demand, HDAM will be continu-
ously improved and updated.
Conclusion
HDAM contains hundreds of rigorously curated human
mutations from NGS studies and was created to provide a
comprehensive view of these mutations that confer
susceptibility to the common disorders. These data will
provide an available and standardized resource for large-
scale studies. However, due to the unformatted mutation
descriptions in the publications, it is a time-consuming
and labor intensive task for the mutation examination and
disease category. HDAM extends the effect of standar-
dized database, and makes mutation descriptions more
standard in publications. Large-scale mutation disease/
traits studies provide more systematic and functional view
Figure 2 Mutation and gene distribution on circos diagrams. The outer circle represents the chromosomes of the reference genome hg19
with chromosome band labeled. The blue rectangles in light blue ring are the mutated genes in OMIM. The green triangles in light green ring
are genes in HDAM. The red dots in light red ring are the mutations recorded in HDAM. The text in middle represents statistics of mutation
types in HDAM.
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by integrating amount of mutations, disease/traits, and
also various types of omics data. As a core of genome-
wide annotation, genomic position is considered as the
most important criterion in data correction. Nonetheless,
disease category is hard to be selected, updated and com-
pared with others, which is more complicated than muta-
tion correction. Thus, standardization in the related field
is urgently in demand. HDAM tries to contain HPO,
OMIM and ICD definitions simultaneously, and builds a
mutation-directed mapping table for further evaluation.
The new predicted mutation-disease relations based on
integrating OMIM allelic variants data and protein-protein
network also provide possible new underlying causes for
the related diseases.
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